Evidence map›Paper›PMID 41688899›Full record

ArticleBMC genomics2026

The Microtus fortis chromosome-level genome: illuminating adaptive evolution and natural parasite immunity.

Du Zhang, Qianwen Zhou, Qi Hu, Tianqiong He, Jieling Xiao, Junkang Zhou, Yixin Wen, Qian Liu, Jing Zhang, Wenlin Zhi and 4 more

Abstract read
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Du Zhang *Department of Medical Genetics, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
Qianwen Zhou *Changsha Health Vocational College, Changsha, 410000, China.
Qi HuE-Gene Biotechnology Co., Ltd., Shenzhen, 518038, China.
Tianqiong HeDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Jieling XiaoDepartment of Medical Genetics, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
Junkang ZhouDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Yixin WenDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Qian LiuDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Jing ZhangDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Wenlin ZhiDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Lingxuan OuyangDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Suisui GaoDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Ruotong GuanDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China.
Zhijun ZhouDepartment of Laboratory Animal Science, Xiangya School of Medicine College, Central South University, Changsha, 410013, China. zhouzhijun@csu.edu.cn.

Funding

Changsha Major Special Project of Science and Technology kh2301027Key Research and Development Program of Hunan Province 2024DK2001Natural Science Foundation of Hunan Province 2024JJ5422Natural Science Foundation of Hunan Province 2024JJ6494
6 · The paper itself

Abstract

The reed vole (Microtus fortis) serves as a significant rodent model, particularly distinguished by its robust natural resistance to Schistosoma japonicum infection. To unravel the genetic basis of this remarkable immunity, we present the first chromosome-level genome assembly for M. fortis. Employing PacBio HiFi long-read sequencing combined with Hi-C scaffolding, we constructed a high-quality 2.29 Gb genome. This assembly is anchored into 26 pseudomolecules, achieving a contig N50 of 68.89 Mb and incorporating 97.73% of the sequence into scaffolds. The genome demonstrates high completeness (BUSCO score 96.3%, glires_odb10) and a repeat content of 42.93%. Comparative genomic analysis revealed a high degree of synteny (95%) and a well-conserved chromosomal structure between M. fortis and Mus musculus.Phylogenetic analysis positions M. fortis diverging approximately 4.9 million years ago from other examined Microtus species and supports its classification within the Alexandromys subgenus. Notably, gene family evolution analysis identified significant expansions in immunity-related pathways. These expansions prominently involve T-cell receptor (TRAV, TRBV) and Major Histocompatibility Complex (MHC) class I and II genes. Further analysis highlighted an extensive lineage-specific expansion and diversification of the MHC class I gene family, predominantly clustered on chromosome 22. These genomic attributes, particularly the amplified T-cell receptor and MHC gene repertoires, are likely key contributors to the potent immune response and natural parasite resistance of M. fortis. This high-quality genome assembly provides an invaluable resource for advancing research into the adaptive evolution and unique biological traits of M. fortis, especially its parasite resistance mechanisms.

Indexed as

ArvicolinaeEvolution, MolecularGenomeGenomicsAnimalsPhylogenySchistosoma japonicumAdaptive evolutionComparative genomicsGenome assemblyMHC gene expansionMicrotus fortisSchistosoma japonicum resistance

Identifiers

PMID41688899
PMCPMC13005530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.